Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2006-11-21
2010-10-26
Huynh, Phuong (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S185100, C424S192100, C530S350000
Reexamination Certificate
active
07820165
ABSTRACT:
This disclosure relates to hybrid antigen binding molecules including at least two polypeptide chains, with at least one polypeptide chain comprises an antigen binding moiety linked to an amino acid sequence of a subunit of a heterodimeric proteinaceous hormone. Also disclosed are methods of making and using such hybrid antigen binding molecules for diagnosis and/or therapy.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4800159 (1989-01-01), Mullis et al.
patent: 4889803 (1989-12-01), Revel et al.
patent: 4965188 (1990-10-01), Mullis et al.
patent: 5225539 (1993-07-01), Winter et al.
patent: 5453491 (1995-09-01), Takatsu et al.
patent: 5530101 (1996-06-01), Queen et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5589369 (1996-12-01), Seidman et al.
patent: 5591669 (1997-01-01), Krimpenfort et al.
patent: 5599905 (1997-02-01), Mosley et al.
patent: 5639605 (1997-06-01), Kitamura et al.
patent: 5648273 (1997-07-01), Bettaro et al.
patent: 5658570 (1997-08-01), Newman et al.
patent: 5686292 (1997-11-01), Schwall et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5693780 (1997-12-01), Newman et al.
patent: 5756096 (1998-05-01), Newman et al.
patent: 5811524 (1998-09-01), Brams et al.
patent: 5892019 (1999-04-01), Schlom et al.
patent: 5939598 (1999-08-01), Kucherlapati et al.
patent: 5969108 (1999-10-01), McCafferty et al.
patent: 6075181 (2000-06-01), Kucherlapati et al.
patent: 6194177 (2001-02-01), Campbell et al.
patent: 6696245 (2004-02-01), Winter et al.
patent: 0 125 023 (1984-11-01), None
patent: 0 417 014 (1991-03-01), None
patent: 0 455 460 (1991-11-01), None
patent: 0 522 530 (1993-01-01), None
patent: 0 368 684 (1994-03-01), None
patent: 0 240 975 (1994-08-01), None
patent: 0 417 563 (2000-07-01), None
patent: 1541689 (2005-06-01), None
patent: WO 90/07861 (1990-07-01), None
patent: WO 02/053596 (2002-07-01), None
patent: WO 2007/047829 (2007-04-01), None
Cary Queen, et al., Proc. Natl. Acad. Sci. USA, 86, pp. 10029-10033 (1989).
C. Stahli, et al., Methods in Enzymology, 92, pp. 242-253 (1983).
Theo N. Kirkland, et al., J. Immunol., 137(11), pp. 3614-3619 (1986).
Harlow and Lane, Antibodies: A Laboratory Manual, Cold Spring Harbor Press (1988).
Guillemette A. Morel, et al., Molecular Immunology, 25(1), pp. 7-15 (1988).
Ramsey C. Cheung, et al., Virology, 176, pp. 546-552 (1990).
G. Moldenhauer, et al., Scand. J. Immunol., 32, pp. 77-82 (1990).
W. Paul. ed., Fundamental Immunology, 2nd ed. Raven Press, N.Y., Chapter 7, 1989.
Kabat, Sequences of Polypeptides of Immuological Interest, National Institutes of Health, Bethesda, MD (1987 and 1991).
Cyrus Chothia, et al., J. Mol. Biol., 196, 901-917 (1987).
Cyrus Chothia, et al., Nature, 342(6252), pp. 877-883 (1989).
Cyrus Chothia, J. Mol. Biol., 186, pp. 651-663 (1985).
G. Kohler, et al., Nature, 256(5517), pp. 495-497 (1975).
Goding, Monoclonal Antibodies: Principles and Practice, pp. 59-103 (Academic Press) 1986.
Zoltan A. Nagy, et al., Nature Medicine, 8(8), pp. 801-807 (2002).
Michael A. Huie, et al., PNAS, 98(5), pp. 2682-2687 (2001).
Bin Liu, et al., J. Mol. Biol., 315, pp. 1063-1073 (2002).
James D. Marks, et al., Bio/Technology, 10, pp. 779-783 (1992).
Jozef Hanes, et al., Nat. Biotechnol., 18, pp. 1287-1292 (2000).
David S. Wilson, et al., PNAS, 98(7), pp. 3750-3755 (2001).
Robert A. Irving, et al., J. Immunol. Methods, 248, pp. 31-45 (2001).
Eric T. Boder, et al., PNAS, 97(20), pp. 10701-10705, (2000).
Patrick S. Daugherty, et al., J. Immunol. Methods, 243, pp. 211-227 (2000).
Roland Newman, et al., Biotechnology, 10, pp. 1455-1460 (1992).
Current Protocols in Immunology, Colligan, et al., Eds., Green Publishing Associates and Wiley Interscience, John Wiley and Sons, New York (1991.
Itai Benhar and Ira Pastan, Protein Engineering, 7(11), pp. 1509-1515 (1994).
F. Ruberti, et al., J. Immunol. Methods, 173, pp. 33 (1994).
James W. Larrick, et al., Biochem. Biophys. Res. Commun., 160(3), 1250-1256 (1989).
Rosaria Orlandi, PNAS, 86, pp. 3833-3837 (1989).
Danielle Sblattero, et al., Immunotechnology, 3, pp. 271-278 (1998).
Anke Krebber, et al., J. Immunol. Methods, 201, pp. 35-55 (1997).
Steffan N. Ho, et al., Gene, 77, pp. 51-59 (1989).
Robert M. Horton, et. al., Methods in Enzymology, 217, pp. 270-279 (1993).
William D. Huse, et al., Science, 246, pp. 1275-1281 (1989).
Eric T. Boder, et al., Nature Biotechnology, 15, pp. 553-557 (1997).
Joseph A. Francisco, et al., PNAS, 90, pp. 10444-10448 (1994).
George Georgiou, et al., Nature Biotechnology, 15, pp. 29-34 (1997).
Hennie R. Hoogenboom, et al., Immunotechnology, 4, pp. 1-20 (1998).
Greg Winter, et al., Annu. Rev. Immunol., 12, 433-455 (1994).
Andrew D. Griffiths, et al., Curr. Opin. Biotechnol., 9, pp. 102-108 (1998).
Jozef Hanes, et al., PNAS, 95, pp. 14130-14135 (1998).
J. Hanes, et al., Curr. Top. Microbiol. Immunol., 243, pp. 107-122 (1999).
Mingyue He, et al., Nucleic Acids Research, 25(24), pp. 5132-5134 (1997).
Hennie R. Hoogenboom, et al., J. Mol. Biol., 227, pp. 381-388 (1992).
Andrew D. Griffiths, et al., The EMBO Journal, 13(14), pp. 3245-3260 (1994).
John De Kruif, et al., J. Mol. Biol., 248, pp. 97-105 (1995).
Carlos F. Barbas, et al., PNAS, 89, pp. 4457-4461 (1992).
Julia Thompson, et al., J. Mol. Biol., 256, pp. 77-88 (1996).
Urpo Lamminmaki, et al., J. Mol. Biol., 291, pp. 589-602 (1999).
R. Craig Caldwell, et al., PCR Methods and Applications, 2, pp. 28-33 (1992).
R. Craig Caldwell, et al., PCR Methods and Applications, 3, S136-S140 (1994).
John Devereaux, et al., Nucleic Acids Research, 12(1), pp. 387-395 (1984).
Tatiana A. Tatusova, et al., FEMS Microbiology Letters, 174, pp. 247-250 (1999).
Current Protocols in Molecular Biology, John Wiley & Sons, N.Y., 6.3.1-6.3.6 (1989).
Francis J. Morgan, et al., J. Biol. Chem., 250(13), pp. 5247-5258 (1975).
John C. Fiddes, et al., Nature, 281, pp. 351-356 (1979).
Paul C. Watkins, et al., DNA, 6(3), 205-212 (1987).
Alan Munro, Nature, 312, pp. 597 (1984).
Michael S. Neuberger, et al., Nature, 312, pp. 604-608 (1984).
J. Sharon, et al., Nature, 309, pp. 364-367 (1984).
Sherie L. Morrison, et al., PNAS, 84, pp. 6851-6855 (1984).
Sherie L. Morrison, Science, 229, pp. 1202-1207 (1985).
Gabrielle L. Boulianne, et al., Nature, 312, pp. 643-646 (1984).
Fang Chen, et al., Molecular Endocrinology, 6(6), pp. 914-919 (1992).
Jakyoung Yoo, et al., J. Biol. Chem., 268(18), pp. 13034-13042 (1993).
Sheri A. Kostelny, et al., Journal of Immunology, 148(5), pp. 1547-1553 (1992).
John De Kruif, et al., Journal of Biological Chemistry, 271(13), 7630-7634 (1996).
Arkinstall Stephen J.
Campbell Robert K.
De Luca Giampiero
He Chaomei
Jiang Xuliang
EMD Serono, Inc.
Huynh Phuong
Merck Serono S.A.
Stein Pascal A.
LandOfFree
Compositions and methods of producing hybrid antigen binding... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods of producing hybrid antigen binding..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods of producing hybrid antigen binding... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4166328